BioSpace News Archive

The latest allowances from the USPTO address systems and methods specific to the dosing of subcutaneous insulin for acute and chronic care.

Alpine Immune Sciences, Inc. provided a corporate update and reported financial results for the year ended December 31, 2017.

Innovative Partnership Will Raise Awareness for Colorectal Cancer Which Is The Third Most Commonly Diagnosed Cancer

bluebird and Celgene will share 50% of U.S. costs and profits

“Improved Methods and Devices for Cellular Analysis” (CA2703631) covers the SnapPath® Cancer Diagnostics System technology “Compositions and Methods for Prediction of Drug Sensitivity, Resistance, and Disease Progression” (CA2795362) covers PathMAP® Functional Signaling Profile technology

Magellan Health, Inc. (NASDAQ: MGLN) today announced that Mostafa Kamal, chief executive officer of Magellan Rx Management, and Casey Stockman, vice president medical pharmacy for Magellan Rx Management, will participate in a panel discussion at the Nephron Research Pharma Pricing and Benefit Management Symposium on Thursday, April 12, 2018, at the Benjamin Hotel in New York.

Evolve Biologics, the biologics division of Therapure Biopharma Inc., today announced that in February 2018 the company confidentially submitted a draft registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common shares.

As of March 27, 2018, Rite Aid has completed the store transfer process, and all 1,932 stores and related assets have been transferred to WBA in exchange for cash proceeds of $4.157 billion.

NOVAROCK has entered into a license agreement for use of The Trianni Mouse™, a best-in-class fully humanized transgenic mouse platform, in support of NOVAROCK’s monoclonal antibody discovery research.

Laboratory network standardizes on common NGS platform to efficiently profile patient samples across multiple cancer centers